Tag
Indian pharmaceutical industry
![COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit](https://thediplomat.com/wp-content/uploads/2021/10/sizes/thumbnail/thediplomat_2021-10-08-18.jpg)
COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit
By Hannah Elyse Sworn
The valuable experience gained by Asian companies during the pandemic could upset the West’s monopoly in high-value drugs more generally, with implications for global access to medicines.
![Sputnik Over Delhi: Production of Russian Vaccine Kicks Off in India Sputnik Over Delhi: Production of Russian Vaccine Kicks Off in India](https://thediplomat.com/wp-content/uploads/2021/10/sizes/thumbnail/thediplomat_2021-10-01-7.jpg)
Sputnik Over Delhi: Production of Russian Vaccine Kicks Off in India
By Krzysztof Iwanek
India’s COVID-19 vaccine production reflects its critical global position. The country is manufacturing its own, plus European, American, and Russian, vaccines.
![Putting the Serum Institute of India’s Success in Perspective Putting the Serum Institute of India’s Success in Perspective](https://thediplomat.com/wp-content/uploads/2021/03/sizes/thumbnail/thediplomat-2021-03-11-5.jpg)
Putting the Serum Institute of India’s Success in Perspective
By Krzysztof Iwanek
AstraZeneca’s cooperation with the Serum Institute of India is a success for the Make in India campaign, but not necessarily the idea of a self-reliant India.
![Tramadol: The Dangerous Opioid From India Tramadol: The Dangerous Opioid From India](https://thediplomat.com/wp-content/uploads/2018/01/sizes/thumbnail/thediplomat-50_mg_tramadol_hcl_tablets_generic_ultram_marketed_by_amneal_pharmaceuticals.jpg)
Tramadol: The Dangerous Opioid From India
By Natalie Tecimer
The United States need to work closely with India to ensure tramadol misuse does not escalate at home.
Page 1 of 1